Etropal AD operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Etropal AD with three other
medical equipment manufacturers in Europe:
sales of 5.02 million Euros [US$5.68 million]
of which 100%
was Implants and Surgical instruments),
Pixium Vision Sa
(1.78 million Euros [US$2.02 million]
Safe Orthopaedics SAS
based in FRANCE
(4.70 million Euros [US$5.32 million]
of which 57%
was Indirect Sales).
During the year ended December of 2019, sales at
Etropal AD were 6.81 million Bulgarian Levas (US$3.94 million).
decrease of 17.9%
versus 2018, when the company's sales were 8.30 million Bulgarian Levas.